Ifp Advisors, Inc Zentalis Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$20.23 - $31.73 $283 - $444	14 Added 1.02%	1,382 $42,000
Q2 2022 Sep 06, 2022	BUY	$17.91 - $52.25 $24,500 - $71,478	1,368 New	1,368 $41,000
Q2 2022 Aug 12, 2022	SELL	$17.91 - $52.25 $24,500 - $71,478	-1,368 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$41.58 - $80.89 $5,571 - $10,839	134 Added 10.86%	1,368 $63,000
Q1 2022 Aug 08, 2022	BUY	$41.58 - $80.89 $498 - $970	12 Added 0.98%	1,234 $56,000
Q4 2021 Jan 12, 2022	BUY	$66.92 - $84.79 $81,776 - $103,613	1,222 New	1,222 $102,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.